All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Solid Organ Transplantation Hub is an independent medical education platform, sponsored by Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View solid organ transplantation content recommended for you
Results from a single-center, retrospective study evaluating the impact of suboptimal graft function (SGF) on outcomes in recipients of deceased donor kidney transplants (DDKT) between February 2006 and January 2014 were published in Transplantation Proceedings by Mok et al. SGF was defined as a nadir serum creatinine >1.5 mg/dL within the first month post-transplant; a nadir serum creatinine ≤1.5 mg/dL was classified as standard graft function. The primary outcomes were 10-year graft and patient survival.
Key data: Graft survival was lower in patients with SGF (n = 64) vs those with standard graft function (n = 230) at 5 years (82.3% vs 92.7%) and 10 years (63.2% vs 89.1%; p < 0.0001). In contrast, graft survival at 10 years was comparable in patients with delayed graft function (DGF) vs those without (76.5% vs 84.6%; p = 0.11). Recipients of grafts from donors aged ≥60 years had lower estimated 5-year (71.4% vs 92.8%) and 10-year graft survival (62.4% vs 86.6%; p < 0.0001) than those receiving grafts from donors aged <60 years. Patient survival did not differ between patients with SGF vs those with standard graft function at 5 years (100% vs 94.8%) or 10 years (89.0% vs 91.0%; p = 0.47).
Key learning: In this study, SGF within the first month after DDKT was associated with worse 10-year graft survival but not patient survival vs standard graft function, while donor age ≥60 years was associated with worse graft survival vs donor age <60 years. These findings highlight the potential prognostic value of early post-transplant renal function and donor characteristics for long-term graft outcomes in DDKT.
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
This content is accurate as of the date of publication and is not updated retrospectively. Please refer to the latest available evidence, guidelines, and relevant regulatory information when making clinical decisions.
Your opinion matters
Which topic, relating to ECP, do you think would be the most valuable educational content for the SOT Hub?